![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61K 38/38 | |||
A61P 7/04 |
(11) | Number of the document | 3481416 |
(13) | Kind of document | T |
(96) | European patent application number | 17742959.4 |
Date of filing the European patent application | 2017-07-07 | |
(97) | Date of publication of the European application | 2019-05-15 |
(45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/067127 |
Date | 2017-07-07 |
(87) | Number | WO 2018/007601 |
Date | 2018-01-11 |
(30) | Number | Date | Country code |
201662359745 P | 2016-07-08 | US |
(72) |
VOIGT, Christine, US
PULI, Shilpa, US
ROBERTS, John, US
NOLTE, Marc, DE
|
(73) |
CSL Behring Lengnau AG,
Industriestrasse 11, 2543 Lengnau BE,
CH
|
(54) | SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS |
SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS |